BVMF
PNVL3
Market cap225mUSD
Jun 05, Last price
8.45BRL
1D
-1.05%
1Q
3.05%
Jan 2017
-62.11%
Name
Dimed SA Distribuidora de Medicamentos
Chart & Performance
Profile
Dimed S.A. Distribuidora de Medicamentos sells medicines, perfumeries, personal care and beauty products, cosmetics, and dermocosmetics in Brazil. It operates in Retail and Wholesale segments. The company offers products through distribution centers in the states of Rio Grande do Sul, Paraná, and Espírito Santo. It operates 517 stores in Rio Grande do Sul, Santa Catarina, Paraná, and São Paulo. The company was formerly known as Panvel S.A. Drogarias e Farmacias and changed its name to Dimed S.A. Distribuidora de Medicamentos in April 2000. The company is headquartered in Eldorado do Sul, Brazil.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 4,942,462 10.79% | 4,461,017 11.79% | 3,990,475 23.72% | |||||||
Cost of revenue | 3,660,025 | 4,343,972 | 2,968,078 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 1,282,437 | 117,045 | 1,022,397 | |||||||
NOPBT Margin | 25.95% | 2.62% | 25.62% | |||||||
Operating Taxes | 7,055 | (1,321) | (7,915) | |||||||
Tax Rate | 0.55% | |||||||||
NOPAT | 1,275,382 | 118,366 | 1,030,312 | |||||||
Net income | 105,509 13.57% | 92,905 7.60% | 86,345 8.71% | |||||||
Dividends | (33,165) | (28,721) | (24,752) | |||||||
Dividend yield | 2.53% | 1.44% | 1.64% | |||||||
Proceeds from repurchase of equity | (2,997) | 1,360 | (160) | |||||||
BB yield | 0.23% | -0.07% | 0.01% | |||||||
Debt | ||||||||||
Debt current | 292,728 | 266,896 | 270,488 | |||||||
Long-term debt | 1,624,225 | 1,395,943 | 1,237,768 | |||||||
Deferred revenue | (1,167) | |||||||||
Other long-term liabilities | 15,002 | 13,851 | 15,678 | |||||||
Net debt | 1,827,670 | 1,414,056 | 1,482,537 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 224,449 | 296,621 | 205,480 | |||||||
CAPEX | (122,724) | (114,419) | (181,637) | |||||||
Cash from investing activities | (55,693) | (196,558) | (131,085) | |||||||
Cash from financing activities | (116,714) | (97,825) | (103,115) | |||||||
FCF | 952,402 | 243,267 | 806,005 | |||||||
Balance | ||||||||||
Cash | 213,408 | 245,389 | 157,355 | |||||||
Long term investments | (124,125) | 3,394 | (131,636) | |||||||
Excess cash | 25,732 | |||||||||
Stockholders' equity | 982,568 | 1,201,998 | 1,137,530 | |||||||
Invested Capital | 2,485,521 | 2,184,222 | 1,963,630 | |||||||
ROIC | 54.62% | 5.71% | 56.01% | |||||||
ROCE | 51.60% | 5.30% | 52.04% | |||||||
EV | ||||||||||
Common stock shares outstanding | 149,114 | 149,717 | 149,145 | |||||||
Price | 8.80 -34.13% | 13.36 31.76% | 10.14 -23.87% | |||||||
Market cap | 1,312,206 -34.40% | 2,000,220 32.26% | 1,512,330 -24.26% | |||||||
EV | 3,139,876 | 3,414,276 | 2,994,867 | |||||||
EBITDA | 1,492,640 | 317,199 | 1,206,965 | |||||||
EV/EBITDA | 2.10 | 10.76 | 2.48 | |||||||
Interest | 104,880 | 102,573 | 70,025 | |||||||
Interest/NOPBT | 8.18% | 87.64% | 6.85% |